Growth Metrics

Verastem (VSTM) Free Cash Flow Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 66.37%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 137.65%
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn -34.75%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -34.75%
Dec 31, 2025 -19.34%
Sep 30, 2025 -52.20%
Jun 30, 2025 -18.44%
Mar 31, 2025 -36.53%
Dec 31, 2024 15.44%
Sep 30, 2024 -43.44%
Jun 30, 2024 -38.55%
Mar 31, 2024 -39.64%
Dec 31, 2023 -78.63%
Sep 30, 2023 -9.99%
Jun 30, 2023 -56.80%
Mar 31, 2023 -5.21%
Dec 31, 2022 -67.28%
Sep 30, 2022 -39.30%
Jun 30, 2022 5.44%
Mar 31, 2022 1.19%
Dec 31, 2021 54.23%
Sep 30, 2021 -124.31%
Jun 30, 2021 40.44%
Mar 31, 2021 42.63%
Dec 31, 2020 41.69%
Sep 30, 2020 259.93%
Jun 30, 2020 34.99%
Mar 31, 2020 12.28%
Dec 31, 2019 -91.36%
Sep 30, 2019 -19.64%
Jun 30, 2019 -222.86%
Mar 31, 2019 -71.93%
Dec 31, 2018 4.31%
Sep 30, 2018 -96.43%
Jun 30, 2018 25.85%
Mar 31, 2018 -111.75%
Dec 31, 2017 -241.52%
Sep 30, 2017 -96.88%
Jun 30, 2017 -116.43%
Mar 31, 2017 1.57%
Dec 31, 2016 41.70%
Sep 30, 2016 48.20%
Jun 30, 2016 44.32%
Mar 31, 2016 9.23%
Dec 31, 2015 -27.80%
Sep 30, 2015 -8.55%
Jun 30, 2015 -31.79%
Mar 31, 2015 -28.40%
Dec 31, 2014 -21.69%
Sep 30, 2014 -50.58%
Jun 30, 2014 -44.29%
Mar 31, 2014 -46.54%
Dec 31, 2013 -11.03%
Sep 30, 2013 -3.18%
Jun 30, 2013 -24.32%
Mar 31, 2013 -26.11%
Dec 31, 2012 -44.04%
Sep 30, 2012 -48.56%
Jun 30, 2012 -3,037.65%
Mar 31, 2012 -479.58%